§ Same category · GLP-1 / metabolic peptides
AOD-9604 vs Retatrutide
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
AOD-9604
0
vendors tracked
Retatrutide
0
vendors tracked
AOD-9604
Lipolytic GH fragment
No current listings at 5mg.
Retatrutide
Triple GCG/GIP/GLP-1 agonist
No current listings at 10mg.
About AOD-9604
A modified fragment of the C-terminus of human growth hormone studied for its lipolytic effects. Originally developed as an obesity drug candidate.
About Retatrutide
An investigational triple-agonist targeting GLP-1, GIP, and glucagon receptors. Phase 3 clinical trials for obesity are ongoing; research-compound version is sold via research-chemical vendors.